Saturday, April 25, 2026

A CMS proposed rule from April 14 seeks to enforce interoperability standards and prior authorization requirements for Medicare Advantage, Medicaid managed care, and CHIP plans. The rule aims to accelerate electronic data exchange and could standardize how authorization decisions are communicated to practices. While the final rule is pending, the direction signals a push toward API-based data sharing and potentially faster turnaround times for certain requests. The comment period will close 60 days after publication, marking a key deadline for industry feedback that will shape the final requirements.

Major payers UnitedHealthcare, Aetna, and Cigna announced progress adopting standardized prior authorization processes as part of an industry commitment to reduce administrative burden. The Health Care Payment Learning & Action Network initiative aims to streamline forms and reduce variation. For practices, this could mean a slow move toward more uniform requirements across these commercial payers. However, implementation timelines and specific plan-level adoption remain unclear. Monitor your primary payer portals for any announcements about new standardized forms or submission processes in the coming months.

CMS and the FDA jointly announced the RAPID Coverage Pathway on April 23, a new program designed to accelerate Medicare coverage for FDA-designated breakthrough medical devices. The pathway aims to reduce the lag between FDA approval and Medicare reimbursement decisions. For practices that adopt new technologies, this could mean faster and more predictable coverage for qualifying devices, potentially reducing prior authorization delays. The first devices under this pathway are expected in late 2026. Track the FDA's Breakthrough Devices Program list, as those products are likely candidates for this expedited Medicare review.

Representatives Pramila Jayapal and Ro Khanna introduced the "Improving Seniors' Timely Access to Care Act," which would prohibit the use of prior authorization for any medically necessary service covered under traditional Medicare within Medicare Advantage plans. The bill responds to persistent provider and patient complaints about MA plan delays. While its passage is uncertain, the legislation signals mounting political pressure on MA administrative burdens. For now, MA prior auth rules remain in effect, but this legislative push adds to the regulatory scrutiny payers face.

Elevance Health reported stronger than expected Q1 2026 results and raised its full-year profit outlook, citing effective cost management. However, the insurer cautioned that final 2027 Medicare Advantage rates from CMS, expected to be lower than the industry advocated for, could pressure future margins. This follows similar warnings from UnitedHealthcare. The dynamic suggests MA plans may intensify utilization management or seek higher premium increases to offset revenue pressure, which could translate to stricter provider network terms or reimbursement challenges in 2027 contract negotiations.